Development Of A Box–Behnken Design Optimized Linagliptin Liposphere Formulation For Improved Bioavailability And Sustained Release. Journal of Carcinogenesis, [S. l.], v. 24, n. 7s, p. 866–877, 2025. DOI: 10.64149/J.Carcinog.24.7s.866-877. Disponível em: https://carcinogenesis.com/index.php/JOC/article/view/1187. Acesso em: 8 dec. 2025.